This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H9N2 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H9N2 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 28.4 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The H9N2 Hemagglutinin (HA) is a major surface glycoprotein that defines the antigenicity and host range of the H9N2 subtype. It mediates viral entry by binding to sialic acid receptors; notably, many H9N2 lineages have evolved an increased affinity for human-type alpha 2,6-linked receptors, raising pandemic concerns. As the primary target for neutralizing antibodies, HA is essential for vaccine strain selection. Its cleavage site motifs are also critical determinants of viral pathogenicity and systemic spread within avian and mammalian hosts.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.